Diprivan and Xarelto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diprivan (propofol) and Xarelto (rivaroxaban). Common drug interactions include mania among females and mania among males.

The phase IV clinical study analyzes what interactions people have when they take Diprivan and Xarelto. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Diprivan?

Diprivan has active ingredients of propofol. eHealthMe is studying from 6,496 Diprivan users. Check the latest studies of Diprivan.

What is Xarelto?

Xarelto has active ingredients of rivaroxaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 212,377 Xarelto users. Check the latest studies of Xarelto.



On Aug, 12, 2026

30 people who take Diprivan and Xarelto together, and have interactions are studied.

Diprivan and Xarelto drug interactions.

What are the common drug interactions of Diprivan and Xarelto, by gender? *:

female:

  1. Mania (a state of abnormally elevated or irritable mood)
  2. Cardiac arrest
  3. Renal failure (kidney dysfunction)
  4. Drug resistance (reduction in effectiveness of a drug)
  5. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  6. Abdominal infection
  7. Altered state of consciousness (altered state of mind)
  8. Ascites (accumulation of fluid in the abdominal cavity)
  9. Chronic kidney disease
  10. Diplopia (double vision)

male:

  1. Mania (a state of abnormally elevated or irritable mood)
  2. Knee arthroplasty
  3. Logorrhoea (excessive, uncontrollable, or incoherent talkativeness)
  4. Monoplegia (a paralysis of a single limb)
  5. Mood altered (changes in mood)
  6. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  7. Pneumonia
  8. Renal failure (kidney dysfunction)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Infection

What are the common drug interactions of Diprivan and Xarelto, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cardiac arrest
  2. Chronic kidney disease
  3. Epistaxis (bleed from the nose)
  4. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  5. Intracranial aneurysm (bulging, weak area in the wall of a cranial artery)
  6. Renal failure (kidney dysfunction)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)

50-59:

  1. Knee arthroplasty
  2. Post procedural haemorrhage (post procedural bleeding)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Abscess limb (limb infection)
  5. Necrotising fasciitis (an uncommon life-threatening soft-tissue infection)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Infection
  8. Post-traumatic stress disorder

60+:

  1. Mania (a state of abnormally elevated or irritable mood)
  2. Pneumonia
  3. Mood altered (changes in mood)
  4. Renal failure (kidney dysfunction)
  5. Drug resistance (reduction in effectiveness of a drug)
  6. Intestinal ischaemia (decreased supply of oxygenated blood to the intestines)
  7. Abdominal infection
  8. Allergy test positive
  9. Altered state of consciousness (altered state of mind)
  10. Ascites (accumulation of fluid in the abdominal cavity)

What are the existing conditions these people have? *

  1. Haemorrhage (bleeding): 10 people, 33.33%
  2. Anaesthesia: 9 people, 30.00%
  3. Procedural Vomiting: 8 people, 26.67%
  4. Sedation: 4 people, 13.33%
  5. High Blood Pressure: 3 people, 10.00%
  6. Diabetes: 3 people, 10.00%
  7. Weight Decreased: 2 people, 6.67%
  8. Type 2 Diabetes: 2 people, 6.67%
  9. Pain: 2 people, 6.67%
  10. Nausea (feeling of having an urge to vomit): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Diprivan and Xarelto?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diprivan and Xarelto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diprivan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xarelto:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diprivan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xarelto and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on propofol and rivaroxaban (the active ingredients of Diprivan and Xarelto, respectively), and Diprivan and Xarelto (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: